Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 14.38B | 14.00B | 13.30B | 11.89B | 11.55B | 11.91B |
Gross Profit | 13.64B | 14.00B | 13.13B | 11.89B | 11.55B | 11.91B |
EBITDA | 933.00M | 1.41B | 1.72B | 977.00M | 1.63B | 1.00B |
Net Income | 895.00M | 959.00M | 1.21B | 682.00M | 1.18B | 1.20B |
Balance Sheet | ||||||
Total Assets | 67.33B | 66.49B | 64.71B | 60.93B | 48.55B | 54.15B |
Cash, Cash Equivalents and Short-Term Investments | 2.07B | 2.56B | 2.51B | 2.31B | 2.31B | 2.53B |
Total Debt | 2.97B | 2.97B | 3.03B | 2.78B | 2.78B | 2.78B |
Total Liabilities | 57.05B | 55.98B | 54.82B | 52.10B | 52.10B | 7.28B |
Stockholders Equity | 10.28B | 10.51B | 9.89B | 8.82B | -3.56B | 320.00M |
Cash Flow | ||||||
Free Cash Flow | 2.61B | 2.48B | 2.19B | 2.45B | 2.45B | 1.97B |
Operating Cash Flow | 2.71B | 2.57B | 2.29B | 2.50B | 2.50B | 2.00B |
Investing Cash Flow | -980.00M | -1.32B | -1.84B | -1.51B | -1.51B | -1.23B |
Financing Cash Flow | -1.65B | -1.12B | -577.00M | -1.03B | -1.03B | -648.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $5.96B | 13.62 | 15.74% | 2.17% | 3.09% | 168.29% | |
74 Outperform | $7.74B | 9.63 | 15.43% | 1.79% | 6.76% | 54.56% | |
73 Outperform | $5.25B | 23.56 | 7.48% | 1.76% | 13.37% | -35.09% | |
72 Outperform | $6.54B | 23.27 | 17.99% | 0.90% | 9.18% | -16.06% | |
68 Neutral | $12.05B | 13.39 | 8.98% | 4.13% | 6.34% | -28.19% | |
67 Neutral | $16.86B | 11.90 | 9.77% | 3.76% | 12.07% | -8.35% | |
66 Neutral | $10.54B | 13.42 | 18.51% | 7.61% | 3.76% | -9.12% |
On July 3, 2025, CNA Financial entered into a General Release and Separation Agreement with Susan A. Stone, Executive Vice President and General Counsel, with her separation effective no later than July 31, 2025. The agreement includes a payment of $2,250,000 in installments and additional health and welfare benefits. In return, Ms. Stone agreed to non-interference and non-solicitation clauses for 12 months, and to cooperate with ongoing litigation and other matters.
The most recent analyst rating on (CNA) stock is a Sell with a $48.00 price target. To see the full list of analyst forecasts on CNA Financial stock, see the CNA Stock Forecast page.